Emcure Pharmaceuticals IPO: The initial public offering (IPO) for Emcure Pharmaceuticals began on July 3, 2024, and will remain open for bidding until July 5, 2024. The IPO price band has been set between ₹960 to ₹1008 per equity share. The public issue received a strong response on its first day and has garnered bullish interest in the grey market.
Emcure Pharmaceuticals IPO Grey Market Premium
Currently, the grey market premium (GMP) for Emcure Pharmaceuticals IPO is ₹333, which is an increase of ₹38 from the previous day’s GMP of ₹295. This rise is attributed to strong investor interest and a positive trend in the stock market, with the Nifty 50 index reaching a new high above 24,300. Market observers anticipate further increases in the grey market premium.
Subscription Status
As of the first day of bidding, the IPO was subscribed 1.32 times. The retail portion was subscribed 1.39 times, the non-institutional investor (NII) segment was subscribed 2.71 times, and the qualified institutional buyer (QIB) portion was subscribed 0.07 times.
IPO Details
The allotment date for Emcure Pharmaceuticals IPO is expected to be July 6, 2024. If not announced on this date, it will be on July 8, 2024. The IPO is proposed to be listed on the BSE and NSE, with the likely listing date being July 10, 2024.
Disclaimer: Investors are advised to consult certified experts before making any investment decisions.
